1) hepatocyte growth-promoting factor
促肝细胞生长素
1.
Study on optimization of the recipe and technique of hepatocyte growth-promoting factor for injection;
注射用促肝细胞生长素的处方筛选和工艺优化
2.
Therapeutic effect of combined therapy of hepatocyte growth-promoting factor and salviate milttiorrhize on chronic hepatitis B;
促肝细胞生长素联合复方丹参注射液治疗慢性乙肝疗效观察
3.
Influence of hepatocyte growth-promoting factor on proliferation of hepatic stellate cells and activities of α1(Ⅰ ) procollagen gene promoter in rats;
促肝细胞生长素对大鼠肝星状细胞增殖及α1(Ⅰ)胶原基因启动子活性的影响
2) hepatocyte growth-promoting factors
促肝细胞生长素
1.
Acute laryngeal edema caused by hepatocyte growth-promoting factors;
促肝细胞生长素致急性喉头水肿
2.
Combining compound glycyrrhizin with hepatocyte growth-promoting factors for treatment of hepatic fibrosis;
复方甘草甜素合用促肝细胞生长素抗肝纤维化的疗效观察
3.
Combination therapy using hepatocyte growth-promoting factors and Glycyrrhizin in children with acute hepatitis B;
促肝细胞生长素联合甘利欣治疗儿童急性乙型病毒性肝炎
3) pHGF
促肝细胞生长素
1.
Intravenous drip pHGF of one case of anaphylactic shock;
静脉滴注促肝细胞生长素致过敏性休克1例
2.
Clinical study on phentolamine mesilate,thymosin α1 combined with PHGF in the treatment of severe hepatitis.;
酚妥拉明、胸腺肽_(α1)、促肝细胞生长素联合治疗重型肝炎的临床研究
3.
QGY,HepG2 cells and primary rat hepatocytes were cultured separately with hepatopoitin,hepatopoitin disgested by pronase P and glycosidase and PHGF.
方法用链霉蛋白酶P、N-糖苷酶F、O-糖苷酶分别对低分子量肝细胞生长素消化,观察消化后低分子量肝细胞生长素以及未经消化的低分子量肝细胞生长素和促肝细胞生长素对人肝癌细胞株QGY、HepG2、原代大鼠肝细胞的增殖作用,用3H-胸腺嘧啶核苷掺入法测定这些细胞的增殖情况。
4) promoting hepatocyte growth factor
促肝细胞生长素
1.
Research on the downregulating blood sugar effect of promoting hepatocyte growth factor to STZ-induced diabetic mice;
促肝细胞生长素对糖尿病大鼠降糖作用的研究
2.
Therapeutic effect of promoting hepatocyte growth factor on streptozocin induced diabetic rats;
促肝细胞生长素对链佐星损伤性糖尿病大鼠的治疗作用
3.
Effect of the combination of promoting hepatocyte growth factor and insulin to pancreatic islet secretry function of diabetic mice;
促肝细胞生长素与胰岛素合用对糖尿病大鼠胰岛分泌功能的影响
5) hepatocyte growth promoting factor
促肝细胞生长素
1.
A HPLC method was described for determing hepatocyte growth promoting factor (PHGF) concentration in human plasama.
本文建立了用高效液相色谱法测定血中促肝细胞生长素的方法。
2.
Aim To ensure the possibility that bacterial endotoxins test replaces rabbitts test in hepatocyte growth promoting factor.
目的 确定促肝细胞生长素用细菌内毒素检查法替代家兔法的可能性。
3.
AIM: To observe the therapeutic effect of hepatocyte growth promoting factor (PHGF) combined with transmetil in treatment of chronic severe hepatitis (CSF).
目的 :观察促肝细胞生长素联合腺苷蛋氨酸治疗慢重肝的疗效。
6) Powdery Form of PHGF
促肝细胞生长素粉针剂
补充资料:促肝细胞生长素
药物名称:促肝细胞生长素
英文名:Hepatocyte growthpromotting Factors
药理作用:
刺激正常肝细胞DNA合成,促进肝细胞再生,降低谷丙转氨酶,具保肝作用。调节机体免疫功能有免疫增强作用。本品为猪或小牛的肝细胞生长因数(HGF),有明显的促进肝细胞DNA的合成、促进肝细胞再生,能提高实验动物急性肝功能衰竭的存活率。临床多点验证,重型肝炎存活率显著提高,可达70%左右,可重型慢性活动性肝炎的肝功能可有明显改善。
适应症:用于重症肝炎、慢性活动性肝炎等。
用法及用量:
重症肝炎:80~120mg,每日1次,静脉滴注。
慢性肝炎:40~80mg,每日1次,静脉滴注,一疗程为2~3个月。
肌注:20mg/(次·日),直至临床病情基本缓解时为止。
不良反应: 偶可出现低热。
注意事项: 对本品过敏者禁用。成品变棕黄色后不能用。 偶有微热,未见明显的副反应。在病情缓解过程中发现伴有肝脏增大、甲胎蛋白增高的现象。
规格: 注射(冻干粉)剂:每支含多肽20mg
类别:肝胆疾病辅助用药
英文名:Hepatocyte growthpromotting Factors
药理作用:
刺激正常肝细胞DNA合成,促进肝细胞再生,降低谷丙转氨酶,具保肝作用。调节机体免疫功能有免疫增强作用。本品为猪或小牛的肝细胞生长因数(HGF),有明显的促进肝细胞DNA的合成、促进肝细胞再生,能提高实验动物急性肝功能衰竭的存活率。临床多点验证,重型肝炎存活率显著提高,可达70%左右,可重型慢性活动性肝炎的肝功能可有明显改善。
适应症:用于重症肝炎、慢性活动性肝炎等。
用法及用量:
重症肝炎:80~120mg,每日1次,静脉滴注。
慢性肝炎:40~80mg,每日1次,静脉滴注,一疗程为2~3个月。
肌注:20mg/(次·日),直至临床病情基本缓解时为止。
不良反应: 偶可出现低热。
注意事项: 对本品过敏者禁用。成品变棕黄色后不能用。 偶有微热,未见明显的副反应。在病情缓解过程中发现伴有肝脏增大、甲胎蛋白增高的现象。
规格: 注射(冻干粉)剂:每支含多肽20mg
类别:肝胆疾病辅助用药
说明:补充资料仅用于学习参考,请勿用于其它任何用途。
参考词条